What is SHTDY's gross margin?

Sinopharm (SHTDY) has a gross margin of 7% and a net margin of 1%.

What is SHTDY's P/E ratio?

SHTDY's P/E ratio is 5.6 with ROE of 17%.

Where can I see SHTDY's full financials?

See Sinopharm (SHTDY) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Sinopharm (SHTDY) Financials — Revenue, Earnings, Cash Flow

Also trades as: 1099.HK (HKSE) · $vol 11M · SHTDF (OTC) · $vol 0M

$9.35

+0.02 (+0.21%)

Weekly Expected Move ±2.6%

$9 $9 $9 $10 $10

OTC · Healthcare · Medical - Distribution · Tech Score Strong Sell · Power 43 · $5.8B mcap · 255M float · 0.060% daily turnover · Short 27% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

📊 Key Metrics

TTM

$1,139B

Revenue

+9.9% YoY

$14B

Net Income

-21.6% YoY

$37B

Free Cash Flow

+50.1% YoY

6.7%

Gross Margin

2.9%

Op. Margin

1.2%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE17.2%

ROA3.3%

ROIC15.0%

Valuation

P/E5.6

P/B0.5

EV/EBITDA0.0

Leverage

Debt/Equity1.34

Current Ratio1.40

Interest Cov.9.1x

Quality Scores

Piotroski F6/9

Altman Z—

Beneish M-2.74